Clinical Trial Update: Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating DCB-WH1 for healing chronic diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• DCB-WH1

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Chronic Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED